Dr. Dieppa's focus will be treating concussions and brain injuries in patients who have suffered symptoms such as memory problems, headaches and balance. Read More
Dr. Dolce’s clinical and research interests will focus on the diagnosis and treatment of children with epilepsy. Read More
Dr. Gokhale, Assistant Professor of Neurology and Neurotherapeutics and Neurological Surgery, will divide his time between research, clinical care and teaching. Read More
Drs. Roger Rosenberg and Juan Pascual are co-editors of the latest edition of Rosenberg's Molecular and Genetic Basis of Neurologic and Psychiatric Disease. The textbook provides a comprehensive introduction and reference to the foundations and key practical aspects relevant to the majority of neurologic and psychiatric disease. It will be released in November 2014.Added August 06, 2014 - Publications
DaiWai Olson, Ph.D., R.N., was chosen as a fellow of the Neurocritical Care Society. Dr. Olson is only the second nurse to receive this honor. The Neurocritical Care Society has a worldwide membership of healthcare professionals and is dedicated to improving outcomes for patients with life-threatening neurological illnesses.Added August 06, 2014 - Awards
Darin Okuda, M.D. and his colleagues conducting a multi-national study found that individuals with radiologically isolated syndrome (RIS) are at risk for a first clinical attack related to demyelination within the central nervous system; the risk appears to be predicated on age, sex, and the presence of cervical or thoracic spinal cord lesions.
Divyanshu Dubey, M.D., neurology resident, presented two papers at the 2014 International Stroke Conference. Dr. Dubey's work research focused on a combination therapy for ischemic stroke and smartphone applications for stroke.
Susan Iannaccone, M.D.'s, clinical trial of a drug for children with Spinal Muscular Atrophy (SMA) has had promising results. The drug manufacturer, ISIS Pharmaceuticals, reported the drug was well-tolerated at all dose levels and improved disease characteristics. Phase 3 trials are planned for later this year.